BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31655714)

  • 1. Insulin Pumps: Review of Technological Advancement in Diabetes Management.
    Sora ND; Shashpal F; Bond EA; Jenkins AJ
    Am J Med Sci; 2019 Nov; 358(5):326-331. PubMed ID: 31655714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous Glucose Monitoring: Review of an Innovation in Diabetes Management.
    Mian Z; Hermayer KL; Jenkins A
    Am J Med Sci; 2019 Nov; 358(5):332-339. PubMed ID: 31402042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes management in the new millennium using insulin pump therapy.
    Bode BW; Sabbah HT; Gross TM; Fredrickson LP; Davidson PC
    Diabetes Metab Res Rev; 2002; 18 Suppl 1():S14-20. PubMed ID: 11921425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy.
    Renard E
    Curr Opin Pharmacol; 2002 Dec; 2(6):708-16. PubMed ID: 12482735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus evidence-based guidelines for use of insulin pump therapy in the management of diabetes as per Indian clinical practice.
    Kesavadev J; Jain SM; Muruganathan A; Das AK;
    J Assoc Physicians India; 2014 Jul; 62(7 Suppl):34-41. PubMed ID: 25668935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are We Ready to Move Beyond Capillary Glucose Testing and Insulin Injections?
    Galindo RJ; Migdal AL; Umpierrez GE
    Am J Med Sci; 2019 Nov; 358(5):315-316. PubMed ID: 31655712
    [No Abstract]   [Full Text] [Related]  

  • 8. Numerical and clinical precision of continuous glucose monitoring in Colombian patients treated with insulin infusion pump with automated suspension in hypoglycemia.
    Gómez AM; Marín Sánchez A; Muñoz OM; Colón Peña CA
    Endocrinol Nutr; 2015 Dec; 62(10):485-92. PubMed ID: 26531841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siphon effects on continuous subcutaneous insulin infusion pump delivery performance.
    Zisser HC; Bevier W; Dassau E; Jovanovic L
    J Diabetes Sci Technol; 2010 Jan; 4(1):98-103. PubMed ID: 20167172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of the hospitalized diabetes patient with an insulin pump.
    McCrea D
    Crit Care Nurs Clin North Am; 2013 Mar; 25(1):111-21. PubMed ID: 23410650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHICH FACTORS MAY AFFECT THE QUALITY OF LIFE IN PATIENTS WITH TYPE 1 DIABETES MELLITUS USING THE MEDTRONIC VEO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION PUMP?
    Thomakos P; Panagopoulos G; Kepaptsoglou O; Zoupas C; Mitrakou A
    Georgian Med News; 2018 Apr; (277):61-67. PubMed ID: 29745917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection for and initiation of continuous subcutaneous insulin infusion. Proceedings from a workshop.
    Hanas R
    Horm Res; 2002; 57 Suppl 1():101-4. PubMed ID: 11979036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous glucose monitoring and pumps.
    Cohen N
    Aust Fam Physician; 2015 May; 44(5):284-7. PubMed ID: 26042400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
    Szypowska A; Pańkowska E; Lipka M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived Benefits and Barriers Regarding CSII Treatment: Development and Psychometric Evaluation of the Insulin Pump Attitudes Questionnaire (IPA-Questionnaire).
    Bergis D; Roos T; Ehrmann D; Schmitt A; Schipfer M; Haak T; Kulzer B; Hermanns N
    Exp Clin Endocrinol Diabetes; 2021 Aug; 129(8):566-573. PubMed ID: 31426110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [EFFECTIVENESS OF PUMP INSULIN THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (REVIEW)].
    Seidinova A; Ishigov I; Peyami C; Seidinov S
    Georgian Med News; 2018 Nov; (284):51-55. PubMed ID: 30618389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin pump therapy in adults.
    Didangelos T; Iliadis F
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S109-13. PubMed ID: 21864741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technology to Reduce Hypoglycemia.
    Yeoh E; Choudhary P
    J Diabetes Sci Technol; 2015 Jul; 9(4):911-6. PubMed ID: 25883167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.